Submitted by Anonymous (not verified) on 11 January 2024 - 8:00
Opinion/decision on a Paediatric investigation plan (PIP): Rezolsta, darunavir,cobicistat, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0039/2023
Source: